New Zealand markets closed

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.5461+0.0013 (+0.24%)
At close: 04:00PM EDT
0.5458 -0.00 (-0.05%)
After hours: 06:42PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 22.47M
Enterprise value -54.53M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.20
Price/book (mrq)0.34
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.23

Trading information

Stock price history

Beta (5Y monthly) 2.42
52-week change 3-75.73%
S&P500 52-week change 318.96%
52-week high 35.9500
52-week low 30.5030
50-day moving average 30.6247
200-day moving average 31.7351

Share statistics

Avg vol (3-month) 3494.89k
Avg vol (10-day) 3439.09k
Shares outstanding 541.15M
Implied shares outstanding 641.15M
Float 824.75M
% held by insiders 17.75%
% held by institutions 150.85%
Shares short (15 Jul 2024) 4176.78k
Short ratio (15 Jul 2024) 40.33
Short % of float (15 Jul 2024) 40.45%
Short % of shares outstanding (15 Jul 2024) 40.43%
Shares short (prior month 14 Jun 2024) 4121.67k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-631.02%

Management effectiveness

Return on assets (ttm)-28.36%
Return on equity (ttm)-53.55%

Income statement

Revenue (ttm)10.13M
Revenue per share (ttm)0.25
Quarterly revenue growth (yoy)1.90%
Gross profit (ttm)N/A
EBITDA -51.36M
Net income avi to common (ttm)-46.75M
Diluted EPS (ttm)-1.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)81.15M
Total cash per share (mrq)1.97
Total debt (mrq)4.15M
Total debt/equity (mrq)6.23%
Current ratio (mrq)4.67
Book value per share (mrq)1.62

Cash flow statement

Operating cash flow (ttm)-36.44M
Levered free cash flow (ttm)-17.93M